Claudine Bruck

This profile gathers the share dealings of Claudine Bruck across 2 companies, led by Annovis Bio, Inc. and Navidea Biopharmaceuticals, Inc. Over a trading history stretching from 30 June 2021 to 10 September 2025, the count stands at 6 filings.

Purchases make up the whole of the open-market record (1 purchase, €4,333). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 3 share grants and 1 option exercise.

The newest entry dates from 12 November 2025: an option exercise of €854, in Annovis Bio, Inc. The most recent open-market purchase was published on 13 October 2021, 1,831 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.